# Monetizing a medical research graph RAG startup

**Created:** 11/27/2025 2:39:44  
**Updated:** 11/27/2025 11:37:40  
**Exported:** 11/28/2025 8:50:48  
**Link:** [https://claude.ai/chat/e83b43df-f34a-49bf-aed5-7497811be864](https://claude.ai/chat/e83b43df-f34a-49bf-aed5-7497811be864)  

## Prompt:
11/27/2025, 2:39:46 AM

I'm thinking about trying to create an ai-based startup and it's like to brainstorm. The general premise is that I make an alliance with one or more medical journals, where I take they're articles and prepare them to be part of a graph rag system, allowing doctors to get summaries and perform complex queries on them and crops correlate stuff across multiple papers. My partner's doctor was a real bloodhound in figuring out the word stuff that went into getting her an accurate diagnosis and my idea of to make that less labor intensive. The part I don't quite know is how to monetize it.



## Response:
11/27/2025, 2:40:02 AM

This is a compelling idea with real clinical value. The diagnostic detective work you're describing - connecting dots across fragmented research - is genuinely difficult and time-consuming for physicians.

**The monetization challenge you're facing is actually the core strategic question**: Who pays, and why is this valuable enough to them that they'll pay sustainably?

A few paths to consider:

**Direct to physicians/practices** - Subscription model ($50-200/month per provider). The challenge here is that individual doctors don't usually control their tool budgets, and getting them to pay out-of-pocket for yet another tool is tough. You'd need to prove it saves them significant time or improves outcomes measurably.

**Hospital systems/health networks** - Enterprise licenses. This is more promising because they have budgets for clinical decision support tools and care about reducing diagnostic errors (which are expensive). You'd be selling to IT/informatics departments and CMOs. The sales cycles are long (6-18 months) but contracts can be substantial.

**Pharma/biotech companies** - They might pay for insights into how their drugs/conditions are discussed in literature, or for lead generation (identifying potential clinical trial sites). This is lucrative but might create conflicts of interest with your primary mission.

**Medical education** - Licensing to residency programs, CME providers, or medical schools. Smaller contracts but potentially many of them.

**The journal partnership angle cuts both ways**: Journals might see you as adding value (making their content more discoverable/useful) or as a threat (bypassing their paywalls). You'd need to structure deals carefully - perhaps revenue sharing based on which articles get surfaced, or positioning yourself as enhancing rather than replacing their platforms.

What's your sense of who would feel the most acute pain from the current state? Is it individual physicians frustrated by the research process, or administrators worried about diagnostic error rates and liability?



## Prompt:
11/27/2025, 2:42:35 AM

It's analogous to what LexisNexis does with legal documents, is there anything in their business model that can help to figure this out?



## Response:
11/27/2025, 2:42:52 AM

That's an excellent analogy - LexisNexis is actually a perfect template to study here.

**Key elements of their model that translate well:**

**Tiered enterprise licensing** - They don't sell to individual lawyers much; they sell to law firms and corporate legal departments with seat-based pricing. Large firms pay hundreds of thousands annually. This maps directly to selling to hospital systems rather than individual doctors.

**Professional necessity positioning** - LexisNexis became infrastructure that legal professionals *must* have to do their jobs competently. Missing a relevant case precedent could mean malpractice. Similarly, missing relevant research in a complex diagnosis could be liability. That "can't practice without it" positioning is powerful.

**Content licensing as the foundation** - LexisNexis licenses content from courts, publishers, etc. and the value-add is aggregation, search, and analytics. You'd be doing the same with medical journals. They likely pay journals/publishers for access, then markup significantly on the tooling layer.

**Shepard's Citations model** - This is their killer feature: showing how cases cite each other and which precedents are still valid. Your graph RAG approach is essentially building "Shepard's for medical research" - showing how studies relate, contradict, or build on each other. That's genuinely novel value.

**Professional vs. academic tiers** - They have different pricing for law schools vs. practitioners. You could have cheaper academic/training licenses and premium clinical decision support licenses.

**The revenue model**: LexisNexis is subscription-based with enterprise contracts typically $100-500+ per user annually, but sold in bulk. A 100-physician hospital system might pay $20-50K/year, larger systems much more.

**Your biggest hurdle compared to LexisNexis**: They had decades to become entrenched before digital disruption. You're entering a market where PubMed is free and UpToDate already exists. You need to be dramatically better at the specific use case (complex diagnostic correlation) rather than trying to be everything to everyone.

What's your relationship with the journals like so far? Are they receptive, or is that still theoretical?



## Prompt:
11/27/2025, 2:47:36 AM

No relationship whatsoever with any journal, entirely speculation at this point. But this raises the possibility of (at least initially) using pubmed as the source of papers, there's causing noone concern. And I can develop the whole graph rag system and get it tuned up with free open input content, so that if a journal deal is feasible later, I've got the system ready to go.



## Response:
11/27/2025, 2:47:51 AM

That's a much smarter approach - validate the tech and the value proposition with PubMed before trying to negotiate partnerships that might not even be necessary.

**PubMed gives you some real advantages:**

**Immediate access to ~36 million citations** - including full text for PMC articles. No negotiations, no revenue sharing, no delays. You can start building today.

**Clear legal footing** - It's publicly funded research, explicitly meant for this kind of use. No ambiguity about whether you can index and analyze it.

**Credibility signal** - Starting with "all of PubMed" is actually more impressive than "we have exclusive deals with 3 journals." Physicians want comprehensive coverage for diagnostic work, not siloed content.

**PMC Open Access subset** - About 4+ million full-text articles you can process directly. That's a substantial corpus for developing your graph RAG system.

**The real question becomes**: What's the actual moat if anyone can access PubMed? Your value is entirely in:
- **The graph construction** - How you identify relationships, contradictions, and connections between papers
- **The query interface** - Making complex medical queries actually work (this is harder than it sounds)
- **The relevance ranking** - Surfacing the right papers for diagnostic scenarios
- **Clinical workflow integration** - Getting it into the tools doctors actually use

LexisNexis succeeded not because they had exclusive content, but because their search, citation analysis, and interface were vastly superior to alternatives. The content was somewhat commoditized even then.

**If you build something physicians find genuinely useful with PubMed**, journals might actually approach *you* wanting to be included, rather than the other way around. Or you might realize you don't need them at all.

Have you thought about what the MVP query interface looks like? Are you thinking chatbot-style Q&A, or something more structured for diagnostic workup?



## Prompt:
11/27/2025, 2:51:59 AM

I would want to talk to that doctor, she is now also my PCP. Find out what she would want for an interface and a feature set, what she would hope to find in such a product. I have thoughts about how to do the ingestion but what to prioritize structurally, is want more domain expertise than I have.



## Response:
11/27/2025, 2:52:14 AM

That's the right move - she's essentially your ideal design partner. She has:
- **Demonstrated expertise** in the exact use case (complex diagnostic detective work)
- **Personal stake** in better tools (she clearly cares about getting diagnoses right)
- **Your trust** and existing relationship (easier to have candid conversations)

**When you talk to her, I'd structure it around:**

**Her actual workflow for that diagnostic case** - Walk through it step-by-step. What did she search for? Where did she look? What connections did she make? What was tedious vs. what required her expertise? This gives you the real pain points, not hypothetical ones.

**What she wished existed** - Not "would you use X?" but "when you were chasing down that diagnosis, what would have made it faster?" Let her describe the fantasy tool first, before you pitch yours.

**How she'd query it** - Show her different interface concepts (chat, structured forms, graph visualization, timeline views) and see what resonates. Medical professionals often think differently about information retrieval than engineers do.

**Integration points** - Does she want this in her EMR? As a separate tool? On her phone between patients? The best tech in the world fails if it doesn't fit the workflow.

**What would make her trust it** - This is critical. She needs to see citations, confidence levels, contradictory evidence. Medical professionals are appropriately skeptical of black boxes.

One concrete thing: offer to build her a prototype focused specifically on the condition/diagnostic area from her case. "I want to build the tool that would have helped you with [partner's diagnosis]. Can I use that as the test case?" That gives you a concrete, bounded problem to solve and validates whether your approach actually works.

Would she be open to that kind of collaboration, do you think?



## Prompt:
11/27/2025, 2:54:35 AM

She might well, and if not, I can probably find somebody else. I also need a money person because I won't be able to float this thing on my own savings.



## Response:
11/27/2025, 2:54:54 AM

You're at an interesting inflection point - you need capital, but how much and from whom depends heavily on what you learn from that doctor conversation.

**Before you go looking for money, you want to know:**

**Can you build an MVP on nights and weekends?** - If you can get something working with PubMed/PMC that demonstrates the concept (even if rough), you're in a vastly better position. Investors want to see "here's the thing working" not "here's my idea for a thing."

**What's the minimum viable system?** - Full graph RAG with everything is expensive to build and run. But could you start with something narrower? Maybe focus on one medical specialty or condition category initially? Rheumatology and autoimmune conditions (like your partner's case) might be perfect - they're notoriously difficult diagnostically and involve connecting lots of disparate symptoms.

**What's your burn rate?** - Are you trying to raise enough to quit your job and do this full-time? Or raise enough to contract out some development while you keep working? Those are very different numbers.

**Funding paths to consider:**

**Bootstrapped MVP first** - 3-6 months of your time nights/weekends, AWS costs under $500/month initially. Get something doctors can actually try. Then fundraise with traction.

**Angel investors** - If you have a working prototype and 5-10 doctors saying "I'd pay for this," you might raise $100-250K from angels (often doctors themselves, or people who've had medical frustrations). Enough to work full-time for a year.

**Healthcare-focused VCs** - They want to see more traction (paying customers, clear unit economics), but if you can show this solves a real problem they'll pay attention. Think $1M+ seed rounds.

**Grant funding** - NIH SBIR grants, digital health foundations. Slower but non-dilutive. Requires more paperwork but fits your "improving diagnostic accuracy" mission.

**Co-founder vs. advisor** - Do you need a "money person" as a co-founder (equity split, full-time commitment) or an advisor/fractional CFO who helps with fundraising for smaller equity? At the idea stage, most finance people won't quit their jobs to join you.

Given your LexisNexis background and AWS expertise, you could probably build an impressive proof-of-concept in a few months. Have you sketched out what the technical architecture would look like?



## Prompt:
11/27/2025, 2:55:57 AM

Nights and weekends, dude, I just lost my job. If I can get this things lined up before I crash and burn it becomes my day job.



## Response:
11/27/2025, 2:56:12 AM

Right, sorry - I missed that context. So this isn't a side project, it's potentially your next thing. That changes the timeline significantly.

**You're in a compressed decision window:**

**How long can you self-fund?** - 3 months? 6 months? That determines whether you need money *before* you build anything, or whether you can build first and fundraise with traction.

**Can you build a convincing demo in 4-6 weeks?** - Not production-ready, but enough to show a doctor and have them say "holy shit, yes." Something that ingests a subset of PubMed, builds the graph, and can answer a few diagnostic queries well. If yes, you're better off building than pitching vaporware.

**Do you need a co-founder or can you contract/defer?** - For the money/business side, you probably don't need a full-time CFO right now. You need someone who can help with pitch decks, financial projections, and introductions to investors. That might be an advisor (1-3% equity) rather than a 20-30% co-founder split.

**The fast path might be:**
1. **Week 1-2**: Talk to your PCP and 2-3 other doctors. Validate the problem, understand what they'd pay for.
2. **Week 3-8**: Build focused MVP - maybe just autoimmune/rheumatology cases using PMC open access articles. Get the graph RAG working for that vertical.
3. **Week 9-10**: Show it to those doctors again. Get LOIs (letters of intent) if possible - "I would pay $X/month for this."
4. **Week 11-12**: Pitch angels with: working demo + doctor validation + your domain expertise (30 years engineering, healthcare tech experience at LexisNexis).

The convincing narrative is: "I just spent 2 months building what took LexisNexis years to figure out for legal, but for medicine. Here's doctors who want it."

What's your runway look like realistically?



## Prompt:
11/27/2025, 2:58:06 AM

Btw you mentioned something called uptodate, what is that? And pmc, is that just all abbreviation for pubmed?



## Response:
11/27/2025, 2:58:17 AM

**UpToDate** is the incumbent clinical decision support tool - it's essentially the thing you'd be competing with (or complementing). It's a subscription service owned by Wolters Kluwer where physicians look up clinical guidance. Think of it as evidence-based clinical summaries written by expert physicians, organized by condition/treatment. It's widely used - many hospital systems provide it to their doctors. It doesn't do what you're describing (graph-based research correlation), but it's the established "I need to look something up" tool for clinicians. Worth understanding what it does well and where it falls short for complex diagnostic cases.

**PMC** is PubMed Central - it's related to but distinct from PubMed:

**PubMed** - A search engine/database of ~36 million biomedical citations and abstracts. Run by NIH/NLM. You can search and see abstracts for free, but full text often requires journal subscriptions.

**PubMed Central (PMC)** - A subset of PubMed that contains full-text articles (~8 million articles), including a large open access collection you can download and process freely. This is what you'd likely want to start with since you need full text to build your knowledge graph, not just abstracts.

So your starting corpus would probably be the PMC Open Access Subset - several million full-text articles you can legally download, process, and build your graph from. That's substantial enough to prove the concept.

Does that clarify the landscape?



## Prompt:
11/27/2025, 3:06:31 AM

Yeah thanks, that's very helpful. I can stay afloat for those 12 weeks you envision but I wouldn't want to commit to it  without some early proof of viability.



## Response:
11/27/2025, 3:06:44 AM

Smart - don't burn 12 weeks and your runway on something that might not work. You need early validation gates.

**A more cautious path with decision points:**

**Week 1-2: Doctor interviews (low cost, high signal)**
- Talk to your PCP and maybe 1-2 others if you can get intros
- Key questions: Would they use this? What would they pay? What's their current process?
- **Decision gate**: If they're lukewarm or say "UpToDate already does this," you've learned something important for almost no cost

**Week 3-4: Technical spike (prove the hard part)**
- Download a small PMC subset (maybe 10,000 articles in one specialty)
- Build a minimal graph RAG pipeline - just prove you can extract entities, build relationships, and query it
- Test on a few known diagnostic cases from the doctor conversations
- **Decision gate**: Does the graph actually surface useful connections? Or is it just keyword salad? If the tech doesn't work at small scale, it won't work at large scale

**Week 5-6: Show doctors the prototype**
- Take what you built back to the same doctors
- Can it answer their diagnostic questions better/faster than their current process?
- **Decision gate**: Do they get excited and say "I'd pay for this" or "this is interesting but..."? The difference matters

**If all three gates pass, THEN you commit to the full build and fundraising push.** If any gate fails, you've spent 4-6 weeks and minimal money learning this isn't the path, and you can pivot to job searching or a different idea.

Does that feel like a more manageable risk profile?



## Prompt:
11/27/2025, 6:10:13 AM

In a parallel chat, I'm going over some technical matters of this project and had the following interesting idea. 

**Pivot:**
"From research discovery tool to clinical decision support" 

or 

"From literature search to evidence-based clinical guidance"

**Scope impact:**

**Broader:** 
- User base expands from researchers to practicing physicians (much larger market)
- Query types become more practical/immediate (diagnosis, treatment) vs. exploratory
- Response format shifts from "here are relevant papers" to "here's what evidence suggests, with citations"

**Narrower:**
- No PHI handling = no HIPAA compliance infrastructure
- Avoids EHR integration complexity initially
- Focuses purely on query→guidance pipeline over public literature

**Net effect:** More commercially viable, technically simpler regarding compliance, but higher bar for response quality - doctors need actionable guidance, not just paper lists. The RAG synthesis becomes more critical than pure retrieval.



## Response:
11/27/2025, 6:10:30 AM

That's a significant reframing - and honestly, a better one commercially. You're moving from "better PubMed" to "better UpToDate" which is a much clearer value proposition.

**The pivot makes sense because:**

**Clearer user need** - "Help me diagnose this complex case" is more urgent than "help me find research papers." Doctors will pay more for clinical guidance than literature search.

**Avoiding the EHR trap early** - Not touching PHI initially is huge. You can build, test, and sell without navigating HIPAA compliance, BAAs with hospitals, or integration with Epic/Cerner. That's easily 12-18 months and significant legal costs you're deferring.

**Different competitive position** - You're not competing with PubMed (free, entrenched). You're offering an *alternative* to UpToDate that's more current and better at connecting dots across studies. UpToDate is human-curated summaries updated periodically. You're AI-synthesized guidance from the latest research, updated continuously.

**The technical challenge shifts:**
- Retrieval is table stakes - you need the right papers
- **Synthesis quality becomes critical** - Can your RAG system produce guidance that's accurate, appropriately hedged, and clearly sourced? This is harder than just returning papers
- **Conflicting evidence handling** - When studies disagree, you need to surface that intelligently, not just pick one

**For your doctor interviews, this changes the questions:**

Instead of: "Would you use a better way to search medical literature?"

Ask: "When you're facing a complex diagnostic case, what do you wish existed to help you? What do you use now and where does it fall short?"

The narrow scope (no PHI) also means your MVP can be simpler: a web interface where doctors paste anonymized clinical presentations and get evidence-based guidance with citations. No integrations, no patient data, just query→response.

Does this reframing feel right, or does it lose something important from your original vision?



## Prompt:
11/27/2025, 6:12:09 AM

Sounds good to me, I definitely want to make money with this thing.



## Response:
11/27/2025, 6:12:19 AM

Good - clarity on that matters. This is a business, not a research project.

**Your core bet is now:** Can you build clinical decision support that's good enough for doctors to trust and pay for, using AI synthesis of medical literature instead of human-curated summaries?

If yes, you're attacking a proven market (UpToDate generates hundreds of millions in revenue annually) with a potentially better approach (more current, better at complex correlations, AI-native).

**Next concrete steps:**

1. **Doctor conversation this week** - Frame it around clinical decision support, not literature search. "I'm building a tool to help with complex diagnostic cases. Walk me through how you figured out [partner's diagnosis]."

2. **Technical validation (weeks 2-4)** - Build the simplest version that could possibly work: Take a known complex case, ingest relevant PMC articles, generate clinical guidance. Does it produce something a doctor would trust?

3. **If that works, talk money** - "If this tool could reliably help you with cases like this, what would you pay? $100/month? $500/month? Would your hospital system pay for it?"

The beautiful thing about this pivot: you'll know pretty quickly if it works. Either the synthesis is good enough to be useful or it isn't. Either doctors would pay for it or they wouldn't.

You've got 12 weeks of runway and 30 years of engineering experience. If anyone can build a convincing prototype in that timeframe, you can.

When can you talk to your PCP?



## Prompt:
11/27/2025, 7:11:24 AM

My PCP is an extremely no-nonsense person who works way too many hours and I bet she would consider such a conversation a waste of time without a live demo. I don't think she'd agree to it. I think I'd be better off approaching somebody like Peter Diamandis, who holds an MD and handles in the startup space. No idea if he's involved in clinical practice but I think he'd me a lot more receptive.



## Response:
11/27/2025, 7:11:40 AM

You're probably right about your PCP - if she's overworked and pragmatic, "let me pick your brain about a hypothetical tool" is a non-starter. She needs to see something real.

**Peter Diamandis is an interesting choice** - he's definitely startup-friendly, understands innovation, and has the MD credibility. But he's also not a practicing clinician (hasn't been for decades) and is famously hard to reach unless you're already in his network. He's more likely useful later for visibility/credibility than for early product validation.

**What you actually need right now:**
- Practicing physicians who deal with complex diagnostics regularly
- Who are tech-forward enough to engage with an early prototype
- Who you can actually reach

**Some more accessible paths:**

**Academic medical centers** - Teaching hospitals often have physicians doing research who are more open to conversations about tools. They're incentivized to engage with innovation. Look for clinical informatics departments or diagnostic medicine specialists.

**Online medical communities** - There are physician groups on Reddit (r/medicine), Doximity, SERMO where doctors discuss cases and tools. You could post: "I'm building clinical decision support for complex diagnostics, looking for physicians who'd give feedback on an early prototype."

**Your network** - Do you or Lori know any physicians through friends/family? Even specialists in other areas might have colleagues in diagnostic-heavy fields (rheumatology, infectious disease, neurology).

**Medical informatics conferences** - AMIA, HIMSS - these attract physicians interested in health tech. Virtual attendance is cheap.

But honestly? **Build the demo first.** If you approach anyone - Diamandis or a random resident - with "here's a working prototype, try it on a case you found difficult" you'll get engagement. With just an idea, you're asking for free consulting.

What's the fastest path to a working demo you can show someone?



## Prompt:
11/27/2025, 11:37:25 AM

That before a technical exercise, which is the other chat. In broad strokes, it is

- design the system, at least at a block diagram level
- learn cdk, which I wanted to learn anyway
- grab N documents from pmc for input
- iterate and debug the ingestion process until that works, that will require defining a schema I guess 
- start doing some queries and inferences and see what quality of output I can get
- debug and refine

The technical minutiae are in the other chat (https://claude.ai/chat/444a87c0-3699-417e-939e-9fe9d4800d7f). It will start with nailing down a reasonable schema and a solid ingestion process.



## Response:
11/27/2025, 11:37:40 AM

Good - you've got the technical roadmap clear in your head and the other chat for implementation details. That separation makes sense.

**From a business/strategic perspective while you're building:**

**Document your assumptions** - As you're iterating on schema and ingestion, keep notes on what worked and why. When you eventually pitch this, "I tried X approaches and here's why Y won" is compelling. Shows you're not just coding, you're solving a real problem thoughtfully.

**Pick your N documents strategically** - Don't just grab random PMC articles. Pick a specific clinical scenario (ideally the one from your partner's case, or another complex diagnostic puzzle) and pull the ~50-200 papers that would be relevant to that case. That way your prototype can actually answer "here's a real case, what does the literature suggest?" rather than just "the system works in theory."

**Define success criteria early** - Before you start querying/inference, write down what "good output" looks like. If a physician saw this response, would they trust it? Would it save them time? Would they pay for it? Having that bar defined prevents you from optimizing for the wrong thing.

**Timeline reality check** - That full cycle (design through refined output) is probably 6-8 weeks of focused work, maybe more if you're learning CDK from scratch. That's fine, fits your runway, but means you're probably not talking to potential users/investors until late January/early February. Plan accordingly.

While you're heads-down building, keep the business questions percolating in the background. The technical work will surface insights about what's actually hard/valuable that will inform your eventual pitch.
